INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

66,143 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MA
Merriman Dwight ADirector
MDBMongoDB, Inc.
Open-market sale · 10b5-1 plan
SELL$294K
860 sh
Nov 2, 2026Nov 4, 2026
Page 73 of 1654
← PrevNext →
traded Nov 2, 2026
+2d
SEC Form 4

Evidence

9
CV
Coloma Jason VDirector, Chief Executive Officer
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$166K
5,345 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
DE
Davis Robert EmersonDirector
HTZHERTZ GLOBAL HOLDINGS, INC
Grant or award
A—
58.6K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
MM
Matsuda MasaruEVP, Chief Legal Officer
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
1,219 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
20.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
20.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
CG
Clark Joseph GatesSVP and Pres, Optimized LED
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
900 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
18.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
SB
Sensenig BethanyDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
8,252 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Hall John TDirector, Chief Executive Officer
INTAIntapp, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
300 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
CG
Clark Joseph GatesSVP and Pres, Optimized LED
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$46K
900 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
5,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$526K
24.7K sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
PJ
Piazza Nicholas J.Senior VP & CPO
EMREMERSON ELECTRIC CO
Tax withholding
F$146K
875 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
SB
Sensenig BethanyDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
24.2K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
MM
McKee Robert MichaelDirector, President & CEO
KGSKodiak Gas Services, Inc.
Open-market sale · 10b5-1 plan
SELL$121K
2,666 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
GL
George Jennifer LSEVP and COO
CBFVCB Financial Services, Inc.
Option exercise
M—Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
BG
Baszucki GregoryDirector
RBLXRoblox Corp
Open-market sale · 10b5-1 plan
SELL$140K
3,048 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
BR
Burchianti RalphDirector
CBFVCB Financial Services, Inc.
Option exercise
M—Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
6,250 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
CG
Clark Joseph GatesSVP and Pres, Optimized LED
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
1,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
2,500 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
VJ
Vecchio JenniferGroup President and CMO
BURLBurlington Stores, Inc.
Open-market sale · 10b5-1 plan
SELL$119K
505 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
VJ
Vecchio JenniferGroup President and CMO
BURLBurlington Stores, Inc.
Open-market sale · 10b5-1 plan
SELL$147K
618 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
13.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
TD
Tsao DavidDirector, Chief Technology Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$2,603
23 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Hall John TDirector, Chief Executive Officer
INTAIntapp, Inc.
Open-market sale · 10b5-1 plan
SELL$4,239
100 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
TD
Tsao DavidDirector, Chief Technology Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
100 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
TD
Tsao DavidDirector, Chief Technology Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$34K
300 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
13.5K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
14.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,375 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,500 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
100.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$526K
24.7K sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
25.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
WS
Wampler Kira SchererDirector
DOCSDoximity, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
2,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
SB
Sensenig BethanyDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
4,977 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
BG
Baszucki GregoryDirector
RBLXRoblox Corp
Open-market sale · 10b5-1 plan
SELL$140K
3,052 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. BUYMTDRMatador Resources CoNov 5 – Nov 56 insiders$507K
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K